Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnostic tests for hepatitis C

D R Gretch1

  • 1Department of Laboratory Medicine, University of Washington Medical Center, Seattle 98195, USA.

Hepatology (Baltimore, Md.)
|September 26, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of the AST to platelet ratio index in HCV/HIV co-infected patients.

Alimentary pharmacology & therapeutics·2011
Same author

Laboratory approaches to the diagnosis of hepatitis C virus infection.

Minerva gastroenterologica e dietologica·2005
Same author

Use and interpretation of HCV diagnostic tests in the clinical setting.

Clinics in liver disease·2004
Same author

Prospective multicenter clinical evaluation of AMPLICOR and COBAS AMPLICOR hepatitis C virus tests.

Journal of clinical microbiology·2001
Same author

Investigating hepatitis C virus heterogeneity in a high prevalence setting using heteroduplex tracking analysis.

Journal of virological methods·2001
Same author

Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response.

Journal of virology·2001
Same journal

Decoding fibrosis: Transcriptomic and clinical insights via AI-derived collagen deposition phenotypes in MASLD.

Hepatology (Baltimore, Md.)·2026
Same journal

A randomized controlled trial of stepped treatment to reduce unhealthy alcohol use in patients with chronic liver disease.

Hepatology (Baltimore, Md.)·2026
Same journal

AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Candidate evaluation.

Hepatology (Baltimore, Md.)·2026
Same journal

H4K12 lactylation drives TREM2high macrophages differentiation in liver fibrosis.

Hepatology (Baltimore, Md.)·2026
Same journal

Good vibrations: Using VCTE to predict hepatic decompensation in MASLD.

Hepatology (Baltimore, Md.)·2026
Same journal

One size does not fit all: Global variability in noninvasive testing for MASLD.

Hepatology (Baltimore, Md.)·2026
See all related articles

Hepatitis C diagnostics include serological tests for antibodies and molecular tests for viral RNA. Newer generations improve antibody detection, while RNA tests confirm infection and monitor treatment, though standardization remains a challenge.

Area of Science:

  • Virology
  • Immunology
  • Molecular Diagnostics

Background:

  • Hepatitis C virus (HCV) infection diagnosis relies on serological and molecular assays.
  • Serological tests detect anti-HCV antibodies, with three generations showing improved sensitivity.
  • Molecular assays detect and quantify HCV RNA, confirming active infection and aiding treatment monitoring.

Framework:

  • Serological assays include screening (EIA) and supplemental (RIBA) tests.
  • Third-generation tests (EIA-3, RIBA-3) utilize antigens from multiple HCV genes.
  • Molecular diagnostics employ polymerase chain reaction (PCR) for HCV RNA detection and quantification.

Implementation:

  • HCV RNA detection via PCR confirms active infection and response to antiviral therapy.

Related Experiment Videos

  • Quantitative PCR offers high sensitivity for viral load determination.
  • Branched-chain DNA (BDNA) assays provide precise viral load measurement.

    • Implications:

    • Standardization and proficiency testing are crucial for reliable HCV PCR diagnostics.
    • Current limitations include dynamic range and variability in PCR assays, and sensitivity in BDNA tests.
    • Molecular genotyping of HCV is under development, with clinical significance yet to be fully established.